TrialDrugs2026

Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial.

Qiang Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.